STOCK TITAN

Medicale Financials

MCLE
Source SEC Filings (10-K/10-Q) Updated Feb 17, 2026 Currency USD FYE September

This page shows Medicale (MCLE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality
0.56x

For every $1 of reported earnings, Medicale generates $0.56 in operating cash flow (-$23K OCF vs -$41K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-4.5x

Medicale earns $-4.5 in operating income for every $1 of interest expense (-$33K vs $8K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
-$41K
YoY+29.3%

Medicale reported -$41K in net income in fiscal year 2025. This represents an increase of 29.3% from the prior year.

EPS (Diluted)
$-0.01
YoY+0.0%

Medicale earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$0
YoY-100.0%

Medicale held $0 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
6M
YoY+0.0%
5Y CAGR+11.7%

Medicale had 6M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

MCLE Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $3K0.0% $3K N/A $4K-43.0% $6K-58.2% $15K N/A $9K
Operating Income $3K+200.0% -$3K N/A -$4K+43.0% -$6K+58.2% -$15K N/A -$9K
Interest Expense $2K0.0% $2K N/A N/A N/A $2K N/A N/A
Income Tax N/A $0 N/A $0 $0 $0 N/A $0
Net Income $5K+200.0% -$5K N/A -$6K+33.2% -$8K+50.4% -$17K N/A -$10K
EPS (Diluted) $0.00 $0.00 N/A $0.00 $0.00 $0.00 N/A $0.00

MCLE Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets N/A $0 $0 $0 $0-100.0% $1590.0% $1590.0% $159
Current Assets N/A $0 $0 $0 $0-100.0% $1590.0% $1590.0% $159
Cash & Equivalents N/A $0 $0 $0 $0-100.0% $1590.0% $1590.0% $159
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities N/A $145K+3.8% $140K+8.2% $129K+4.5% $124K+7.0% $116K+16.8% $99K+20.5% $82K
Current Liabilities N/A $32K-4.3% $34K+14.3% $29K+13.5% $26K+16.9% $22K+43.1% $16K+9.7% $14K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity N/A -$145K-3.8% -$140K-8.2% -$129K-4.5% -$124K-7.2% -$116K-16.9% -$99K-20.6% -$82K
Retained Earnings N/A -$222K-2.4% -$217K-5.2% -$206K-2.8% -$201K-4.3% -$193K-9.5% -$176K-10.6% -$159K

MCLE Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow $7K+200.0% -$7K-4.4% -$6K-219.5% -$2K+55.4% -$5K+54.7% -$10K+35.5% -$16K-67.0% -$9K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $7K0.0% $7K+4.4% $6K+219.5% $2K-53.8% $4K-56.3% $10K-35.5% $16K+67.0% $9K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

MCLE Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A -10490.6% N/A -6579.3%
Current Ratio N/A 0.000.0 0.000.0 0.000.0 0.000.0 0.010.0 0.010.0 0.01
Debt-to-Equity N/A -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$140K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

No, Medicale (MCLE) reported a net income of -$41K in fiscal year 2025.

Medicale (MCLE) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Medicale (MCLE) generated -$23K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Medicale (MCLE) had $0 in total assets as of fiscal year 2025, including both current and long-term assets.

Medicale (MCLE) had 6M shares outstanding as of fiscal year 2025.

Medicale (MCLE) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Medicale (MCLE) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Based on fiscal year 2025 data, Medicale (MCLE) had $0 in cash against an annual operating cash burn of $23K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Medicale (MCLE) has negative shareholder equity of -$140K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Medicale (MCLE) has an earnings quality ratio of 0.56x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Medicale (MCLE) has an interest coverage ratio of -4.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top